跳转至内容
Merck
CN

1A04060

USP

N-NITROSOPYRROLIDINE (NPYR) SOLUTION

Pharmaceutical Analytical Impurity (PAI)

别名:

N-Nitrosopyrrolidine (npyr) solution, (1 ml (1 mg/ml) (1-Nitrosopyrrolidine))

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C4H8N2O
化学文摘社编号:
分子量:
100.12
MDL number:
UNSPSC Code:
12352200
NACRES:
NA.24
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

N-NITROSOPYRROLIDINE (NPYR) SOLUTION, Pharmaceutical Analytical Impurity (PAI)

form

liquid

InChI key

WNYADZVDBIBLJJ-UHFFFAOYSA-N

SMILES string

N1(CCCC1)N=O

grade

pharmaceutical analytical impurity (PAI)

agency

USP

manufacturer/tradename

USP

format

neat

storage temp.

-10 to -25°C

application(s)

pharmaceutical small molecule

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Application

N-Nitrosopyrrolidine (NPYR) Solution is intended for use in analytical testing to detect, identify, and measure pharmaceutical impurities.

Features and Benefits

USP PAI advance your early analytical R&D and process development. PAI can be used in the following applications:
1. Conduct analytical tests during early formulation feasibility studies.
2. Determine degradation impurities produced during stress studies.
3. Develop, validate, and transfer analytical methods.
4. Perform spiking studies during process R&D to demonstrate depletion upon recrystallization.
5. Record retention times and/or spectra
6. Determine relative response factors.
7. Identify unknown impurities that formed during ICH stability conditions.
8. Identify impurities that are present in the Reference Listed Drug
9. Test for and profile impurities not listed in drug substance and drug product monographs.

General description

N-Nitrosopyrrolidine (NPYR) Solution is a USP Pharmaceutical Analytical Impurity (PAI).

USP PAI are a product line of impurities suitable for research and analytical purposes, which help to ensure the quality and safety of medicines.

For more information about this PAI, visit here.

Other Notes

Sales restrictions may apply.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
USP issued SDS can be found here

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Carc. 2 - Flam. Liq. 2 - STOT SE 1

target_organs

Eyes,Central nervous system

存储类别

3 - Flammable liquids

wgk

WGK 2

法规信息

危险化学品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持